Which of the following is a good reason for why tobacco smoke is considered a carcinogen?A. 30PIECM^3 B. 35PIECM^3 C. 40PIECM^3 D. 45PIECM^3
Answers
Answer:
5. [PubMed]
Zheng Y, Shen H, Sturgis EM, Wang L-E, Eicher SA, Strom SS, Frazier ML, Spitz MR, Wei Q. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001;22(8):1195–9. [PubMed]
Zheng Y-L, Loffredo CA, Yu Z, Jones RT, Krasna MJ, Alberg AJ, Yung R, Perlmutter D, Enewold L, Harris CC, et al. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls. Carcinogenesis. 2003;24(2):269–74. [PubMed]
Zhong S, Howie AF, Ketterer B, Taylor J, Hayes JD, Beckett GJ, Wathen CG, Wolf CR, Spurr NK. Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis. 1991;12(9):1533–7. [PubMed]
Zhou J, Ahn J, Wilson SH, Prives C. A role for p53 in base excision repair. EMBO Journal. 2001a;20(4):914–23. [PMC free article] [PubMed]
Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Research. 2002a;62(5):1377–81. [PubMed]
Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk. Cancer Epidemiology, Biomarkers & Prevention. 2003;12(4):359–65. [PubMed]
Zhou W, Liu G, Park S, Wang Z, Wain JC, Lynch TJ, Su L, Christiani DC. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer. Cancer Epidemiology, Biomarkers & Prevention. 2005;14(2):491–6. [PubMed]
Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer. Cancer Epidemiology, Biomarkers & Prevention. 2002b;11(1):15–21. [PubMed]
Zhou W, Thurston SW, Liu G, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer. Cancer Epidemiology, Bio-markers & Prevention. 2001b;10(5):461–6. [PubMed]
Zhu BQ, Heeschen C, Sievers RE, Karliner JS, Parmley WW, Glantz SA, Cooke JP. Second hand smoke stimulates tumor angiogenesis and growth. Cancer Cell. 2003;4(3):191–6. [PubMed]
Zhu W, Yamasaki H, Mironov N. Frequency of HPRT gene mutations induced by N-methyl-N’-nitro-N-nitrosoguanidine corresponds to replication error phenotypes of cell lines. Mutation Research. 1998;398(1–2):93–9. [PubMed]
Zhu Y, Doll MA, Hein DW. Functional genomics of C190T single nucleotide polymorphism in human N-acetyl-transferase 2. Biological Chemistry. 2002;383(6):983–7. [PubMed]
Zimmerman CL, Wu Z, Upadhyaya P, Hecht SS. Stereo-selective metabolism and tissue retention in rats of the individual enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), metabolites of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis. 2004;25(7):1237–42. [PubMed]
Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. American Journal of Preventive Medicine. 2003;24(2):190–8. [PubMed]
Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Research. 2001;61(1):249–55. [PubMed]
Go to:
Footnotes
1
Pack-years = the number of years of smoking multiplied by the number of packs of cigarettes smoked per day.
Copyright Notice
Bookshelf ID: NBK53010